Skip to main content
SpringerLink
Log in

Persistent or Recurrent Hypoglycemia in Infants and Todlers

  • Chapter
  • First Online:
Endocrine Conditions in Pediatrics

  • 1203 Accesses

Abstract

The symptoms of hypoglycemia in infants and children can be hard to detect. A high index of suspicion is necessary to avoid the severe consequences of unrecognized and untreated hypoglycemia. The thresholds for activation of counter-regulatory hormones and fasting adaptation are identical in infants ≥72 hours old and older children and adults. A “critical sample” of metabolic fuels and counter-regulatory hormones in the setting of hypoglycemia is the key to understanding the etiology of a patient’s hypoglycemia. Management of most hypoglycemic disorders is a combination of limiting fasting with or without adjunctive therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015;167(2):238–45.

    Article  Google Scholar 

  2. Langdon DR, Stanley CA, Sperling MA. Hypoglycemia in the toddler and child. In: Sperling MA, editor. Pediatric endocrinology. 4th ed. Philadelphia: Elsevier/Saunders; 2014. p. 920–55.

    Chapter  Google Scholar 

  3. Stanley CABL. Hypoglycemia. In: Kaye ROF, Barness LA, editors. Core textbook of pediatrics. Philadelphia: Lippinoctt; 1978. p. 280–305.

    Google Scholar 

  4. Stanley CA, Rozance PJ, Thornton PS, De Leon DD, Harris D, Haymond MW, et al. Re-evaluating “transitional neonatal hypoglycemia”: mechanism and implications for management. J Pediatr. 2015;166(6):1520–5 e1.

    Article  Google Scholar 

  5. Lord K, De Leon DD. Hyperinsulinism in the neonate. Clin Perinatol. 2018;45(1):61–74.

    Article  Google Scholar 

  6. Choo-Kang LR, Sun CC, Counts DR. Cholestasis and hypoglycemia: manifestations of congenital anterior hypopituitarism. J Clin Endocrinol Metab. 1996;81(8):2786–9.

    CAS  PubMed  Google Scholar 

  7. Lord K, De Leon DD, Stanley CA. Hypoglycemia. In: Radovick S, Misra M, editors. Pediatric endocrinology a practical clinical guide. 3rd ed: Springer; 2018. p. 702–13.

    Google Scholar 

  8. De Leon DD, Stanley CA. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab. 2007;3(1):57–68.

    Article  Google Scholar 

  9. Collins JE, Leonard JV. Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia. Lancet (London, England). 1984;2(8398):311–3.

    Article  CAS  Google Scholar 

  10. Hoe FM, Thornton PS, Wanner LA, Steinkrauss L, Simmons RA, Stanley CA. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism. J Pediatr. 2006;148(2):207–12.

    Article  CAS  Google Scholar 

  11. Christiansen CD, Petersen H, Nielsen AL, Detlefsen S, Brusgaard K, Rasmussen L, et al. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation. Eur J Nucl Med Mol Imaging. 2018;45(2):250–61.

    Article  CAS  Google Scholar 

  12. Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med. 2005;46(4):560–6.

    PubMed  Google Scholar 

  13. Otonkoski T, Nanto-Salonen K, Seppanen M, et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes Metab. 2006;55:13–8.

    CAS  Google Scholar 

  14. Adzick NS, De Leon DD, States LJ, Lord K, Bhatti TR, Becker SA, et al. Surgical treatment of congenital hyperinsulinism: results from 500 pancreatectomies in neonates and children. J Pediatr Surg. 2018;

    Google Scholar 

  15. Gibson CE, Boodhansingh KE, Li C, Conlin L, Chen P, Becker SA, et al. Congenital hyperinsulinism in infants with turner syndrome: possible association with monosomy X and KDM6A haploinsufficiency. Horm Res Paediatr. 2018;89(6):413–22.

    Article  CAS  Google Scholar 

  16. Vajravelu ME, De Leon DD. Genetic characteristics of patients with congenital hyperinsulinism. Curr Opin Pediatr. 2018;30(4):568–75.

    Article  CAS  Google Scholar 

  17. Bogershausen N, Gatinois V, Riehmer V, Kayserili H, Becker J, Thoenes M, et al. Mutation update for kabuki syndrome genes KMT2D and KDM6A and further delineation of X-linked kabuki syndrome subtype 2. Hum Mutat. 2016;37(9):847–64.

    Article  Google Scholar 

  18. Alkhayyat H, Christesen HB, Steer J, Stewart H, Brusgaard K, Hussain K. Mosaic Turner syndrome and hyperinsulinaemic hypoglycaemia. J Pediatr Endocrinol Metab. 2006;19(12):1451–7.

    Article  Google Scholar 

  19. Hussain K, Cosgrove KE, Shepherd RM, Luharia A, Smith VV, Kassem S, et al. Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann syndrome due to defects in the function of pancreatic beta-cell adenosine triphosphate-sensitive potassium channels. J Clin Endocrinol Metab. 2005;90(7):4376–82.

    Article  CAS  Google Scholar 

  20. Kalish JM, Boodhansingh KE, Bhatti TR, Ganguly A, Conlin LK, Becker SA, et al. Congenital hyperinsulinism in children with paternal 11p uniparental isodisomy and Beckwith-Wiedemann syndrome. J Med Genet. 2016;53(1):53–61.

    Article  CAS  Google Scholar 

  21. Grand K, Gonzalez-Gandolfi C, Ackermann AM, Aljeaid D, Bedoukian E, Bird LM, et al. Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutations. Am J Med Genet A. 2019;179(4):542–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Peranteau WH, Palladino AA, Bhatti TR, Becker SA, States LJ, Stanley CA, et al. The surgical management of insulinomas in children. J Pediatr Surg. 2013;48(12):2517–24.

    Article  Google Scholar 

  23. Padidela R, Fiest M, Arya V, Smith VV, Ashworth M, Rampling D, et al. Insulinoma in childhood: clinical, radiological, molecular and histological aspects of nine patients. Eur J Endocrinol. 2014;170(5):741–7.

    Article  CAS  Google Scholar 

  24. Palladino AA, Sayed S, Levitt Katz LE, Gallagher PR, De Leon DD. Increased glucagon-like peptide-1 secretion and postprandial hypoglycemia in children after Nissen fundoplication. J Clin Endocrinol Metab. 2009;94(1):39–44.

    Article  CAS  Google Scholar 

  25. Samuk I, Afriat R, Horne T, Bistritzer T, Barr J, Vinograd I. Dumping syndrome following Nissen fundoplication, diagnosis, and treatment. J Pediatr Gastroenterol Nutr. 1996;23(3):235–40.

    Article  CAS  Google Scholar 

  26. Calabria AC, Charles L, Givler S, De Leon DD. Postprandial hypoglycemia in children after gastric surgery: clinical characterization and pathophysiology. Horm Res Paediatr. 2016;85(2):140–6.

    Article  CAS  Google Scholar 

  27. White K, Truong L, Aaron K, Mushtaq N, Thornton PS. The incidence and etiology of previously undiagnosed hypoglycemic disorders in the emergency department. Pediatr Emerg Care. 2018;

    Google Scholar 

  28. Pershad J, Monroe K, Atchison J. Childhood hypoglycemia in an urban emergency department: epidemiology and a diagnostic approach to the problem. Pediatr Emerg Care. 1998;14(4):268–71.

    Article  CAS  Google Scholar 

  29. Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. Rev Endocr Metab Disord. 2003;4(1):95–102.

    Article  CAS  Google Scholar 

  30. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002;161 Suppl 1:S20–34.

    Article  Google Scholar 

  31. Herrera A, Vajravelu ME, Givler S, Mitteer L, Avitabile CM, Lord K, et al. Prevalence of adverse events in children with congenital hyperinsulinism treated with diazoxide. J Clin Endocrinol Metab. 2018;103(12):4365–72.

    Article  Google Scholar 

  32. Vajravelu ME, Congdon M, Mitteer L, Koh J, Givler S, Shults J, et al. Continuous intragastric dextrose: a therapeutic option for refractory hypoglycemia in congenital hyperinsulinism. Horm Res Paediatr. 2018:1–7.

    Google Scholar 

  33. Le Quan Sang KH, Arnoux JB, Mamoune A, Saint-Martin C, Bellanne-Chantelot C, Valayannopoulos V, et al. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrinol. 2012;166(2):333–9.

    Article  Google Scholar 

  34. McMahon AW, Wharton GT, Thornton P, De Leon DD. Octreotide use and safety in infants with hyperinsulinism. Pharmacoepidemiol Drug Saf. 2017;26(1):26–31.

    Article  CAS  Google Scholar 

  35. Ng DD, Ferry RJ Jr, Kelly A, Weinzimer SA, Stanley CA, Katz LE. Acarbose treatment of postprandial hypoglycemia in children after Nissen fundoplication. J Pediatr. 2001;139(6):877–9.

    Article  CAS  Google Scholar 

  36. Wolfsdorf JI, Keller RJ, Landy H, Crigler JF Jr. Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings. J Pediatr. 1990;117(3):384–91.

    Article  CAS  Google Scholar 

  37. De León DD, Thornton PS, Stanley CA, Sperling MA. Hypoglycemia in the Newborn and Infant. In: Sperling MA, editor. Pediatric endocrinology. 4th ed: Elsevier; 2014.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Division of Endocrinology and Diabetes, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Charlene Lai & Diva D. De León

  2. Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

    Diva D. De León

Authors
  1. Charlene Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diva D. De León
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diva D. De León .

Editor information

Editors and Affiliations

  1. Division of Pediatric Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Takara Stanley

  2. Division of Pediatric Endocrinology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Madhusmita Misra

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lai, C., De León, D.D. (2021). Persistent or Recurrent Hypoglycemia in Infants and Todlers. In: Stanley, T., Misra, M. (eds) Endocrine Conditions in Pediatrics. Springer, Cham. https://doi.org/10.1007/978-3-030-52215-5_51

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-52215-5_51

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-52214-8

  • Online ISBN: 978-3-030-52215-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation